Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2874186446;86447;86448 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
N2AB2710081523;81524;81525 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
N2A2617378742;78743;78744 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
N2B1967659251;59252;59253 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
Novex-11980159626;59627;59628 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
Novex-21986859827;59828;59829 chr2:178559911;178559910;178559909chr2:179424638;179424637;179424636
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Fn3-97
  • Domain position: 91
  • Structural Position: 125
  • Q(SASA): 0.648
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/N rs1167302737 0.474 0.986 N 0.737 0.229 0.216624796971 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
D/N rs1167302737 0.474 0.986 N 0.737 0.229 0.216624796971 gnomAD-4.0.0 1.59169E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43324E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.1316 likely_benign 0.1477 benign -0.268 Destabilizing 0.952 D 0.683 prob.neutral N 0.494887079 None None N
D/C 0.4908 ambiguous 0.5654 pathogenic -0.097 Destabilizing 1.0 D 0.774 deleterious None None None None N
D/E 0.09 likely_benign 0.1056 benign -0.252 Destabilizing 0.058 N 0.197 neutral N 0.443996899 None None N
D/F 0.3997 ambiguous 0.4289 ambiguous -0.094 Destabilizing 1.0 D 0.744 deleterious None None None None N
D/G 0.1732 likely_benign 0.1985 benign -0.474 Destabilizing 0.952 D 0.733 deleterious N 0.510299249 None None N
D/H 0.2635 likely_benign 0.2869 benign 0.139 Stabilizing 0.998 D 0.703 prob.delet. N 0.501342189 None None N
D/I 0.1931 likely_benign 0.2175 benign 0.23 Stabilizing 0.995 D 0.769 deleterious None None None None N
D/K 0.2984 likely_benign 0.3251 benign 0.215 Stabilizing 0.979 D 0.754 deleterious None None None None N
D/L 0.2186 likely_benign 0.2461 benign 0.23 Stabilizing 0.989 D 0.753 deleterious None None None None N
D/M 0.3829 ambiguous 0.4292 ambiguous 0.273 Stabilizing 1.0 D 0.776 deleterious None None None None N
D/N 0.1106 likely_benign 0.1195 benign -0.125 Destabilizing 0.986 D 0.737 deleterious N 0.496215231 None None N
D/P 0.4088 ambiguous 0.4873 ambiguous 0.086 Stabilizing 0.995 D 0.776 deleterious None None None None N
D/Q 0.2325 likely_benign 0.2695 benign -0.066 Destabilizing 0.979 D 0.716 prob.delet. None None None None N
D/R 0.3683 ambiguous 0.4055 ambiguous 0.453 Stabilizing 0.989 D 0.756 deleterious None None None None N
D/S 0.1111 likely_benign 0.1244 benign -0.24 Destabilizing 0.963 D 0.693 prob.delet. None None None None N
D/T 0.1718 likely_benign 0.1959 benign -0.074 Destabilizing 0.989 D 0.738 deleterious None None None None N
D/V 0.1245 likely_benign 0.142 benign 0.086 Stabilizing 0.993 D 0.757 deleterious N 0.499215463 None None N
D/W 0.8243 likely_pathogenic 0.8558 pathogenic 0.056 Stabilizing 1.0 D 0.725 deleterious None None None None N
D/Y 0.2001 likely_benign 0.2067 benign 0.143 Stabilizing 0.999 D 0.747 deleterious N 0.50058172 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.